| Title |
Author |
Type |
Date |
Words |
| Supportive Care in Cancer Unveils a Landmark Study Reporting Patients' Unanticipated Skin Toxicities from Anticancer Therapies. |
|
Clinical report |
Jan 6, 2010 |
467 |
| Experimental lung cancer drug may help treat brain, prostate cancer. |
|
|
Jan 5, 2010 |
406 |
| Environmental medicine update: environmental causes of cancer. |
Marchese, Marianne |
|
Jan 1, 2010 |
1666 |
| Leading figures from the real estate and construction industries joined over 1000 guests to raise over $2.04 million at the annual Winter's Eve black-tie dinner to benefit National Jewish Health and to establish The Jonathan L. and Wendy S. Mechanic Fund for Lung Cancer and COPD Research and Treatment Programs. |
|
|
Dec 23, 2009 |
129 |
| Killed by a cancer drug; Widow calls for research on side effects. |
|
|
Dec 22, 2009 |
584 |
| Side effects of cancer drug killed loving great-grandad; Wife wants more medical research. |
|
|
Dec 21, 2009 |
768 |
| Breast cancer drug may reduce risk of death from lung cancer. |
|
|
Dec 12, 2009 |
254 |
| Azaya Therapeutics Receives FDA Authorization to Start Phase I Cancer Trial. |
|
|
Dec 10, 2009 |
366 |
| New way to turn ineffective new cancer drugs into cancer-fighters. |
|
|
Dec 2, 2009 |
310 |
| Research and Markets: Cancer Drug Discoveries: What the Future Holds: Prostate Cancer Chapter. |
|
|
Dec 1, 2009 |
827 |
| Common pain relief drugs promote cancer growth. |
|
|
Nov 23, 2009 |
346 |
| Common pain relief drugs promote cancer growth. |
|
|
Nov 19, 2009 |
346 |
| AVEO's Triple VEGF Receptor Inhibitor Tivozanib in Combination with mTOR Inhibitor Demonstrates Anti-tumor Activity and Tolerability in Advanced Kidney Cancer; Preliminary Results Presented at AACR-NCI-EORTC Meeting. |
|
|
Nov 17, 2009 |
651 |
| Breast cancer drugs may also help beat cervical cancer. |
|
|
Nov 10, 2009 |
243 |
| SCIENTISTS FIND A CURE FOR CANCER; Irish researchers claim new drug kills leukaemia cells. |
|
|
Nov 3, 2009 |
345 |
| Immune system-suppressing drugs 'raise bladder cancer risk'. |
|
|
Oct 28, 2009 |
175 |
| Bio-Matrix Scientific Group Inc. Updates Progress on the Company's New Opportunities in COPD, Tumor Banking and Cancer Treatment. |
|
|
Oct 9, 2009 |
497 |
| Prostate cancer patients on hormone therapy 'at increased heart disease risk'. |
|
|
Sep 23, 2009 |
451 |
| BSD Medical Reports News Briefing at Europe's Largest Cancer Congress: Hyperthermia and Chemotherapy Treatment Prolongs Survival of Sarcoma Cancer Patients. |
|
|
Sep 22, 2009 |
660 |
| Pfizer To Present Research On Established Therapies And New Approaches To Cancer Treatment Using Investigational Agents. |
|
|
Sep 18, 2009 |
1449 |
| Popular diabetes drug may help fight breast cancer. |
|
|
Sep 15, 2009 |
347 |
| GenSpera Receives FDA Approval for G-202 Phase I Cancer Trial. |
|
|
Sep 11, 2009 |
445 |
| Research and Markets: Prostate Cancer Therapy Area Pipeline Report: Status of Prostate Cancer Drugs by Company and by Stage and Summary of the Latest News and Developments. |
|
Report |
Sep 11, 2009 |
352 |
| Natural compounds in vegetables may make chemotherapy more effective. |
|
|
Sep 1, 2009 |
401 |
| Research and Markets: Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report - Drug Status by Company and by Stage as Well as a Summary of the Latest News and Developments. |
|
Report |
Aug 25, 2009 |
350 |
| Breakthrough discovery may help develop breast cancer drug within 2yrs. |
|
|
Aug 25, 2009 |
565 |
| PCF Funding for Bone Metastasis Research Supports New Drug to Improve Lives of Prostate Cancer Patients. |
|
|
Aug 20, 2009 |
1029 |
| New targets for treatment of invasive breast cancer identified. |
|
|
Aug 20, 2009 |
356 |
| Research and Markets: Head and Neck Cancer Therapy Area Pipeline Report - Detailed Information on the Head and Neck Cancer Drug Pipeline. |
|
Report |
Aug 12, 2009 |
360 |
| Research and Markets: Breast Cancer Therapy Area Pipeline Report: Extensive Details on Drug Pipelines by Company and Stage and Latest Company News. |
|
Report |
Aug 12, 2009 |
352 |
| FDA approves pralatrexate for treatment of peripheral T-cell lymphoma. |
|
|
Aug 1, 2009 |
969 |
| Ontario, Canada Leading World-Class Research on New Cancer Drugs. |
|
|
Jul 20, 2009 |
324 |
| Array BioPharma Advances Its Lead MEK Inhibitor into Cancer. |
|
|
Jul 15, 2009 |
1207 |
| Research and Markets: MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2009 Market Report. |
|
Report |
Jul 13, 2009 |
434 |
| Stanford Study Bolsters Case for Preventive Prostate Cancer Treatment. |
|
Report |
Jul 7, 2009 |
879 |
| New hope for cancer patients; Experimental drugs will be on offer. |
|
|
Jul 1, 2009 |
389 |
| Sanofi drug may increase cancer risk, studies find. |
|
|
Jun 27, 2009 |
325 |
| 'Space Age' cancer drug shows promise. |
|
|
Jun 25, 2009 |
241 |
| Bone Cancer Research Trust Calls for New Treatments for Bone Cancer. |
|
|
Jun 18, 2009 |
802 |
| Research and Markets: Bladder Cancer Therapy Area Pipeline Report - A Detailed Information on the Bladder Cancer Drug Pipeline. |
|
Report |
Jun 12, 2009 |
313 |
| New Data Suggest Treatment Regimens That Include ABRAXANE[R] May Be Active in Treating Metastatic Melanoma. |
|
|
Jun 1, 2009 |
2007 |
| New drug olaparib may hold promise for women with genetic breast cancer. |
|
Clinical report |
Jun 1, 2009 |
480 |
| New Data Demonstrate Anti-Tumor Activity for ABRAXANE[R] Combination Chemotherapy Regimen in Patients with Metastatic Pancreatic Cancer. |
|
Clinical report |
May 31, 2009 |
1436 |
| Agios Pharmaceuticals' Focus of Drug Research - Cancer Metabolism - Selected for Stand Up To Cancer Grant. |
|
|
May 28, 2009 |
684 |
| Research and Markets: Cancer Drug Discoveries: What the Future Holds for the Non-Small Cell Lung Cancer Market and Therapeutic Approaches. |
|
|
May 26, 2009 |
774 |
| Arkansas researchers unveil cancer treatment. |
Carter, Mark |
|
May 25, 2009 |
353 |
| Clinical Data, Inc. and Dana-Farber Cancer Institute Form Research Collaboration to Study Role of FCGR3A Gene Variants for Predicting Clinical Outcomes in Breast Cancer Treatment. |
|
|
May 18, 2009 |
1303 |
| AVEO Pharmaceuticals' Scientific Advisory Board Members Recognized for Contributions to Cancer Research and Medicine. |
|
|
May 13, 2009 |
627 |
| Research and Markets: Chinese Markets for Ovarian Cancer Treatment Drugs. |
|
|
May 12, 2009 |
159 |
| Agios Pharmaceuticals Highlights Extensive Cancer Metabolism Research at AACR. |
|
|
Apr 30, 2009 |
644 |
| Bioalliance Pharma Presents Results for Its New Oral Irinotecan Nanoparticle Formulation for the Treatment of Advanced Colorectal Cancer at the American Association for Cancer Research (AACR) 100Th Annual Meeting in Denver, April 18 to 22, 2009. |
|
|
Apr 22, 2009 |
562 |
| Avila Presents Data on Novel, Orally Available, Covalent Drugs Targeting Btk and ErbB Receptors, and Innovative Translational Technology, at Annual AACR Meeting. |
|
|
Apr 21, 2009 |
1006 |
| Abraxis BioScience Presents Data at AACR Showcasing Its Proprietary Nab[R] Technology in the Treatment of Cancer and Its SPARC Biomarker. |
|
Clinical report |
Apr 21, 2009 |
1880 |
| Cholesterol 'increases breast cancer drug's resistance'. |
|
|
Apr 21, 2009 |
414 |
| Halozyme Studies Target Hyaluronan Surrounding Solid Tumors, May Offer New Approach to Cancer Treatment. |
|
|
Apr 20, 2009 |
1175 |
| Allos Therapeutics' Pralatrexate Demonstrates Anticancer Activity in Multiple Cancer Cell Lines. |
|
|
Apr 19, 2009 |
986 |
| Increased Public-Private Partnerships, Expanded Role for NCI Needed to Hasten New Cancer Treatments, Reports "The Oncologist". |
|
|
Apr 14, 2009 |
874 |
| Ash Stevens Inc. CEO to Chair Session on Cancer Drug Development at American Association for Cancer Research Annual Meeting. |
|
|
Apr 8, 2009 |
214 |
| Gynecologic Oncology Group Relies on Ingres Database for Critical Cancer Research and Treatment. |
|
|
Apr 7, 2009 |
675 |
| Aids drug can restrict proliferation of cancer cells. |
|
|
Mar 25, 2009 |
338 |
| Ardea Biosciences to Present Preclinical Multi-Drug Combination Synergy Data on its Lead MEK Inhibitor, RDEA119, at the American Association for Cancer Research 100th Annual Meeting. |
|
|
Mar 20, 2009 |
645 |
| Research and Markets: The Biology and Treatment of Cancer: The Importance of Understanding Cancer. |
|
|
Mar 4, 2009 |
475 |
| Research and Markets: Lung Cancer Drug Pipeline Update 2009. |
|
|
Mar 4, 2009 |
368 |
| Research and Markets: Renal Cancer Drug Pipeline Update 2009. |
|
|
Mar 2, 2009 |
325 |
| Research and Markets: Get the Latest on Prostate Cancer: Drug Pipeline Update 2009. |
|
|
Feb 25, 2009 |
398 |
| Research and Markets: Get the Latest on Breast Cancer with Drug Pipeline Update. |
|
|
Feb 19, 2009 |
301 |
| Research and Markets: Hematological Cancers Drug Pipeline Update 2009. |
|
|
Feb 18, 2009 |
360 |
| Research and Markets: Brain Cancer Drug Pipeline Update 2009. |
|
|
Feb 18, 2009 |
370 |
| Research and Markets: Chinese Markets for Lung Cancer Treatment Drugs. |
|
|
Feb 16, 2009 |
206 |
| Research and Markets: Fundamentals of Drug Delivery in Cancer Revealed in This Recently Updated Report as Approx. 12.5 Million New Cases of Cancer Diagnosed Each Year. |
|
Report |
Feb 12, 2009 |
560 |
| BackOffice Associates Announces Donation to the Thomas Blake Sr. Memorial Research Fund for the Early Detection and Treatment of Cancer. |
|
Company overview |
Feb 12, 2009 |
358 |
| ASPIRIN WARDS OFF STOMACH CANCER; Users of drug 36% less likely to get disease. |
|
|
Feb 6, 2009 |
301 |
| Research and Markets: Chinese Markets for Breast Cancer Treatment Drugs Highlights The Rising Demand For These Drugs In The Past Decade. |
|
|
Feb 3, 2009 |
166 |
| Hollis-Eden Researchers Present New Findings on Mechanism of Action for Anti-Cancer Drug Candidate APOPTONE[TM] (HE3235) at American Association of Cancer Research Meeting. |
|
|
Jan 23, 2009 |
1826 |
| Alnylam Receives Clearance from FDA to Initiate Phase I Study with ALN-VSP for the Treatment of Liver Cancers. |
|
|
Jan 23, 2009 |
915 |
| Experimental drug turns on tumour suppressor gene to halt cancer cell growth. |
|
|
Jan 21, 2009 |
438 |
| Chemotherapy helps lift cancer surgery survival; Treatment cuts death rate by 30%, say city scientists. |
|
|
Jan 20, 2009 |
430 |
| Cough medicine ingredient could prove effective in prostate cancer treatment. |
|
|
Dec 20, 2008 |
434 |
| Common anti-depressant Prozac can fight cancer drug resistance. |
|
Clinical report |
Dec 19, 2008 |
392 |
| Research and Markets: Bladder Cancer - New Drugs Needed to Challenge Ineffective 20-Year Old Drugs. |
|
|
Dec 19, 2008 |
345 |
| Committee for Medicinal Products for Human Use (CHMP) Recommends Granting Marketing Authorisation for FIRMAGON(R) (degarelix) for Treatment of Prostate Cancer. |
|
|
Dec 18, 2008 |
1070 |
| DNA Repair Company Announces New Clinical Findings Which May Help to Guide Breast Cancer Treatment. |
|
|
Dec 12, 2008 |
585 |
| Clinical Data, Inc. Establishes Research Collaboration to Confirm Role of FCGR3A Pathway for Predicting Clinical Outcomes in Breast Cancer Treatment. |
|
|
Dec 11, 2008 |
1222 |
| Sarah Cannon Research Institute Sponsors Large-Scale Breast Cancer Trial. |
|
|
Dec 9, 2008 |
405 |
| Personalised cancer treatment on the anvil. |
|
|
Dec 3, 2008 |
224 |
| Cancer drugs not the only cause of bone loss among survivors. |
|
|
Dec 3, 2008 |
508 |
| Cancer treatment leads to bone loss. |
|
|
Dec 3, 2008 |
420 |
| Personalised cancer treatment on the anvil. |
|
|
Nov 25, 2008 |
224 |
| Cancer drugs not the only cause of bone loss among survivors. |
|
|
Nov 25, 2008 |
508 |
| Cancer treatment leads to bone loss. |
|
|
Nov 25, 2008 |
420 |
| Paloma Pharmaceuticals Publishing Seminal Paper in Cancer Research and Presentation at the AACR Special Conference in Cancer Research. |
|
Conference news |
Nov 17, 2008 |
711 |
| GARDASIL(R), Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study. |
|
|
Nov 13, 2008 |
9491 |
| Ardea Biosciences Presents Preclinical Data on its Lead MEK Inhibitor, RDEA119, Demonstrating Synergy with Other Anti-Cancer Agents in Multiple Tumor Types. |
|
|
Oct 24, 2008 |
891 |
| Ardea Biosciences to Present Clinical Data on its Lead MEK Inhibitor, RDEA119, at the ASCO-NCI-EORTC 2nd Annual Meeting on Molecular Markers in Cancer. |
|
|
Oct 24, 2008 |
638 |
| Boehringer Ingelheim Broadens Oncology Pipeline With Promising New Data for Potentially First in Class Plk1 Inhibitor. |
|
|
Oct 22, 2008 |
1118 |
| Ardea Biosciences Initiates a Phase 1/2 Study of RDEA119, its Lead MEK Inhibitor, in Combination with Nexavar(R) (sorafenib) in Patients with Advanced Cancer. |
|
|
Oct 16, 2008 |
806 |
| NCI Launches First-Ever Study to Determine if Biomarkers Can Help Guide Treatment for Lung Cancer. |
|
|
Oct 2, 2008 |
114 |
| Research and Markets: This Essential Report on Cancer Drug Resistance is Available Now. |
|
|
Sep 17, 2008 |
1103 |
| Study Provides Clues about How Cancer Cells Develop Resistance to Chemotherapy Drug. |
|
|
Sep 15, 2008 |
150 |
| Sarah Cannon Research Institute Presents New Findings in Breast Cancer Treatment. |
|
|
Sep 5, 2008 |
573 |
| Cancer patients left to die; Drugs withheld - study. |
|
|
Aug 11, 2008 |
276 |
| Laboratory and Mouse Studies Show Targeted Drug Blocks the Growth of Breast Cancer Cells that Spread to the Brain. |
|
|
Jul 29, 2008 |
207 |
| Introgen to Present ADVEXIN Phase 3 Study Results at American Association for Cancer Research's Cancer Clinical Trials and Personalized Medicine Conference. |
|
Clinical report |
Jul 17, 2008 |
604 |
| ImmunoGen, Inc. Announces Clinical Findings Reported at ASCO with Targeted Anticancer Compounds IMGN242 and AVE1642. |
|
Clinical report |
Jun 1, 2008 |
1290 |
| Locus Pharmaceuticals Initiates Strategic Inflammatory Cancer Research Collaborations. |
|
|
May 30, 2008 |
1093 |
| Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases. |
|
|
May 27, 2008 |
1062 |
| BIOMAX INFORMATICS AG Selected as a Consortium Partner in the Newly Formed Center for Personalized Cancer Medicine (OncoTyrol). |
|
|
Apr 23, 2008 |
680 |
| Spectrum Pharmaceuticals Presents Data on Lucanthone, a Novel Anticancer Drug, at the Meeting of the American Association of Cancer Research. |
|
|
Apr 17, 2008 |
1121 |
| Anti-cancer mushroom explained. |
|
|
Apr 16, 2008 |
228 |
| Multiple Myeloma Research Consortium and Sunesis Pharmaceuticals Present Data On SNS-032 At American Association of Cancer Research Annual Meeting. |
|
|
Apr 16, 2008 |
580 |
| Further Research on Resveratrol Shows Promise for Treatment of Pancreatic Cancer. |
|
|
Apr 10, 2008 |
816 |
| ASTRO's Official Journal Publishes 12-Year Survival Data Following Landmark Study of Cancer Treatment with Hyperthermia Therapy. |
|
Clinical report |
Apr 2, 2008 |
753 |
| ICA-1 COMPOUND HOLDS PROMISE AS CANCER TREATMENT. |
|
|
Apr 1, 2008 |
363 |
| Researchers Find Cause of Severe Allergic Reaction to Cancer Drug. |
|
|
Mar 13, 2008 |
159 |
| Avastin's Use in Treatment of Metastatic Breast Cancer Expected to Increase Dramatically on Heels of FDA's Accelerated Approval, According to Study by GfK Market Measures. |
|
|
Mar 10, 2008 |
622 |
| Advaxis Scientists Publish Research of Listeria Monocytogenes-Based Vaccine for Prostate Cancer in Latest Edition of Cancer Immunology & Immunotherapy. |
|
|
Mar 4, 2008 |
602 |
| Biothera Drug Synergistic with Avastin(R) Against Cancer, Study Finds. |
|
|
Feb 28, 2008 |
497 |
| HORMONE REPLACEMENT THERAPY HAS RISKS STUDY: WOMEN WHO TAKE MENOPAUSAL MEDICATION MORE LIKELY TO DEVELOP BREAST CANCER. |
|
ST |
Feb 26, 2008 |
525 |
| Sirtris Pharmaceuticals Enters Collaborative Study Testing New Chemical Entities and Clinical Drug Candidate In Multiple Models of Cancer with the National Cancer Institute. |
|
Report |
Feb 21, 2008 |
673 |
| Callisto Announces Guanilib Presentation at the 5th Annual Meeting of Cancer Drugs Research and Development. |
|
Conference news |
Feb 19, 2008 |
760 |
| Drugs trial brings hope for lung cancer patients. |
|
|
Feb 18, 2008 |
406 |
| InNexus Biotechnology Announces Preliminary Results of Animal Study Comparing Cancer Killing Activity of Its DXL625 (CD20) Treatment for Non-Hodgkin's Lymphoma With Leading Marketed Product. |
|
|
Feb 7, 2008 |
712 |
| ApoCell to Conduct Studies in Support of Novel Pfizer Cancer Drug Trial. |
|
|
Jan 24, 2008 |
330 |
| Novel Akt Inhibitor VQD-002 Shown to Reverse Cisplatin Resistance in Ovarian Cancer. |
|
|
Jan 22, 2008 |
1066 |
| Morphotek(R) Announces Initiation of MORAb-009 Phase II Study in First Line Treatment of Pancreatic Cancer. |
|
Disease/Disorder overview |
Jan 7, 2008 |
668 |
| New hope of cancer treatment. |
|
|
Jan 3, 2008 |
128 |
| Test-case patients welcome a new lung cancer drug. |
|
|
Dec 22, 2007 |
555 |
| Cancer Therapeutics CRC and QIMR Collaborate to Discover and Develop Novel Drugs for Cancer Treatment. |
|
|
Dec 19, 2007 |
432 |
| JWCI Researchers Identify Epigenomic Test That Could Improve Treatment for Specific Gastric Cancers. |
|
Clinical report |
Dec 11, 2007 |
698 |
| FDA Approves Phase I Clinical Trial for SKCC Breast Cancer Vaccine. |
|
|
Dec 10, 2007 |
530 |
| NCCN Receives Major Grant for Anti-Cancer Drug Study. |
|
Report |
Nov 15, 2007 |
634 |
| Women at risk needed for cancer drug trials. |
|
|
Nov 14, 2007 |
435 |
| GE and Lilly Announce Research Collaboration to Co-Develop Molecular In Vitro Diagnostics for Cancer Treatments. |
|
|
Oct 1, 2007 |
978 |
| Merck Serono: Safety and Efficacy of Erbitux(R) Confirmed for Combination Trials. |
|
|
Sep 25, 2007 |
2528 |
| Biothera's Imprime PGG Increases Efficacy of Erbitux against Non-Small Cell Lung Cancer, Study Finds. |
|
|
Sep 11, 2007 |
959 |
| Good News to Cancer Patients --- Metabolic Research and Cornerstone Pharmaceuticals Conduct a New Animal Study. |
|
|
Aug 27, 2007 |
517 |
| Ascenta Therapeutics Presents New Clinical Data on AT-101 for the Treatment of Hormone-Refractory Prostate Cancer. |
|
Clinical report |
Aug 24, 2007 |
404 |
| INNOVIVE Pharmaceuticals Announces Second Quarter 2007 Financial Results and Corporate Highlights. |
|
Financial report |
Aug 14, 2007 |
792 |
| Renowned Cancer Drug Researcher Chris Takimoto, M.D., Ph.D., Joins South Texas Accelerated Research Therapeutics. |
|
|
Aug 8, 2007 |
581 |
| Javelin Pharmaceuticals Initiates Phase 3 Breakthrough Cancer Pain Trial for Intranasal Ketamine. |
|
Clinical report |
Jul 31, 2007 |
872 |
| Yale School of Medicine Shows First Detailed View of Molecular Structure May Usher in New Class of Cancer Drugs. |
|
|
Jul 26, 2007 |
451 |
| Aethlon Medical Announces Cancer Treatment Discovery. |
|
|
Jul 18, 2007 |
638 |
| Light Sciences Oncology Initiates Phase III Trial of Its Light Infusion Therapy (Litx(TM)) in Patients with Metastatic Colorectal Cancer. |
|
|
Jul 17, 2007 |
709 |
| Clinical Study Shows Regenecare(R) Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs. |
|
Clinical report |
Jul 11, 2007 |
278 |
| Lpath and Echelon Introduce New Cancer Research Assay Based on Lpath's Breakthrough Anti-Cancer Drug Candidate, Sphingomab(TM). |
|
|
Jul 10, 2007 |
1000 |
| Gorodeski Presents Research on P2X7 for Treatment of Cancer at Purine and Pyrimidine Symposium in Chicago. |
|
|
Jun 26, 2007 |
459 |
| New Research Demonstrates Broad Efficacy of Azixa(TM) (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines. |
|
|
Jun 15, 2007 |
1418 |
| BRITAIN: Hormone therapy breakthrough will help tackle ovarian cancer. |
|
|
Jun 15, 2007 |
379 |
| Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial. |
|
|
Jun 12, 2007 |
912 |
| ApoCell's Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy. |
|
|
Jun 7, 2007 |
420 |
| Drug boosting survival hopes for breast cancer sufferers. |
|
|
Jun 5, 2007 |
268 |
| Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer. |
|
|
Jun 2, 2007 |
2005 |
| Prostate Cancer Patients, Survivors and Advocates Assemble on Capitol Hill to Rally against FDA's Non Approval of Provenge. |
|
|
Jun 1, 2007 |
300 |
| Prostate Cancer Advocates Unite to Fight for Immediate FDA Approval of First-of-Its-Kind Cancer Vaccine. |
|
|
May 23, 2007 |
599 |
| Welsh scientists research alternatives to chemotherapy for treatment of cancer. |
|
|
May 23, 2007 |
195 |
| Targeted Nanoparticles Incorporating siRNA Offer Promise for Cancer Treatment, According to Caltech Researchers. |
|
|
May 20, 2007 |
912 |
| Biothera to Present Cancer Immunotherapy Research at BIO International Convention. |
|
|
May 7, 2007 |
308 |
| Herceptin(R) Approved in Europe for use in Combination With an Aromatase Inhibitor for the Treatment of Patients With HER2 and Hormone Receptor-Co-Positive Metastatic Breast Cancer. |
|
|
May 3, 2007 |
1159 |
| Next Pharmaceuticals Reveals Nexrutine(R) Prevents Prostate Cancer Progression in Pre-clinical Animal Model. |
|
|
May 2, 2007 |
543 |
| Breast Cancer Treatment Pioneer George W. Sledge, Jr, MD, Joins CME Enterprise Advisory Board. |
|
|
May 1, 2007 |
406 |
| AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and Drug-Resistant Lung Cancer. |
|
|
Apr 17, 2007 |
930 |
| Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer. |
|
|
Apr 17, 2007 |
1376 |
| Genomic Predictors Report Likely Response to Multiple Treatments in Breast Cancer. |
|
Clinical report |
Apr 16, 2007 |
484 |
| Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting. |
|
|
Apr 16, 2007 |
1870 |
| Research Supported by Samuel Waxman Cancer Research Foundation Discovers Mode of Action of Arsenic-Based Drugs in Destroying Cancer Cells. |
|
|
Apr 16, 2007 |
610 |
| Mark Davis to Moderate "Novel Approaches to Drug Delivery in Cancer" Session at the AACR Meeting. |
|
|
Apr 12, 2007 |
774 |
| Venture Research Institute (VRI) Announces Plans for FDA Anti-cancer Vaccine Trials. |
|
|
Apr 11, 2007 |
570 |
| Ambit Biosciences Begins Dosing Patients in Phase I Clinical Trial of Lead Kinase Inhibitor AC220. |
|
|
Apr 10, 2007 |
767 |
| Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer. |
|
Clinical report |
Apr 10, 2007 |
2232 |
| INNOVIVE Pharmaceuticals Announces Data from Oncology Drug Programs to be Presented at American Association for Cancer Research Annual Meeting. |
|
|
Apr 10, 2007 |
388 |
| Uni given pounds 5m to fund NHS research; Medical school to test new emergency and cancer treatments. |
|
|
Mar 21, 2007 |
251 |
| Liverpool trials cancer drug; 1,000 patients will take pioneering vaccine. |
|
|
Mar 16, 2007 |
425 |
| New cancer drug for trial in city. |
|
|
Mar 15, 2007 |
158 |
| Breast Cancer; Treatment. |
|
|
Mar 14, 2007 |
2862 |
| Cytogen Announces Initiation of Phase 1 Trial for Radiolabeled Antibody for the Treatment of Hormone-Refractory Prostate Cancer. |
|
|
Feb 27, 2007 |
932 |
| Breast cancer drug bonus. |
|
|
Feb 21, 2007 |
325 |
| WEHI Enters Research Collaboration with Genentech to Develop New Cancer Drugs. |
|
|
Feb 6, 2007 |
401 |
| Callisto's Cancer Drug Atiprimod to Be Presented at the Annual Meeting of American Association of Cancer Research. |
|
|
Jan 25, 2007 |
819 |
| Publication of Early Research on Callisto Pharmaceutical's Degrasyn Drug Class Suggests Potential to Treat Brain Tumors. |
|
Drug overview |
Jan 23, 2007 |
802 |
| Combination of Introgen's Nanoparticles Demonstrate Increased Efficacy in the Treatment of Metastatic Lung Cancer. |
|
Disease/Disorder overview |
Jan 16, 2007 |
709 |
| Focus on cancer drugs' availability. |
|
|
Jan 15, 2007 |
329 |
| Novel drug targets imatinib-refractory leukemia: two studies suggest that nilotinib could provide an alternative for patients not benefiting from imatinib. |
Wilson, Bruce |
|
Jan 15, 2007 |
722 |
| diaDexus Launches Collaboration to Evaluate the Role of Breast Tumor Genes in the Treatment of Breast Cancer. |
|
Disease/Disorder overview |
Jan 10, 2007 |
531 |
| New hope for women; The World Today Cancer drug improves survival chances. |
|
|
Jan 5, 2007 |
276 |
| Can they put a stop to cancer? North scientists' breakthrough could lead to treatment to stop cancer cells growing. |
|
|
Dec 28, 2006 |
540 |
| EpiCept Announces Initiation of Phase I Study of EPC2407 for the Treatment of Cancer. |
|
|
Dec 20, 2006 |
1501 |
| Geron's Telomerase Inhibitor Drug May Benefit Breast Cancer Patients Receiving Radiation Therapy. |
|
|
Dec 19, 2006 |
875 |
| Advaxis Partners with Gynecologic Oncology Group for Phase II Study of Company's Lead Cervical Cancer Vaccine. |
|
|
Dec 19, 2006 |
845 |
| Gaynor's cancer discovery hailed; MEDICINE: Research could help women at high risk of seeing disease return. |
|
|
Dec 8, 2006 |
295 |
| Breast cancer drug is lifesaver. |
|
|
Nov 17, 2006 |
127 |
| Cancer patients may be denied two drugs; Not a good use of resources - watchdog. |
|
|
Nov 14, 2006 |
444 |
| Cancer patients may be denied two drugs. |
|
|
Nov 14, 2006 |
444 |
| The Food and Drug Administration approves the HPV vaccine. |
Suthers, Kristen |
|
Nov 1, 2006 |
703 |
| Research Center for Cancer Drug Design and Discovery Established at Yale University and the National Foundation for Cancer Research. |
|
|
Oct 13, 2006 |
554 |
| New drugs could prevent high-risk women developing breast cancer. |
|
|
Oct 11, 2006 |
435 |
| Hopes for prostate cancer pill. |
|
|
Oct 9, 2006 |
127 |
| Pill trials boost in tumour battles. |
|
|
Oct 9, 2006 |
201 |
| TWO NEW CENTRES TO FIGHT CANCER; pounds 4m for drugs tests. |
|
|
Oct 9, 2006 |
337 |
| SRI International to Conduct Preclinical Studies of Cancer Drug for Taiwan Liposome Company. |
|
|
Oct 3, 2006 |
549 |
| Cancer Drug May Be Remedy for Rheumatoid Arthritis, Stanford Study Finds. |
|
|
Sep 28, 2006 |
899 |
| OSI Pharmaceuticals Launches Study of Tarceva(R) as Adjuvant Treatment for Non-Small Cell Lung Cancer. |
|
|
Sep 21, 2006 |
1163 |
| Number of Cancer Vaccine Players has Decreased through Operational Re-Prioritizations, M&As and Fall Outs. |
|
|
Sep 15, 2006 |
381 |
| An Analytical Tool That Will Help You in Identifying Emerging Cancer Immunotherapy Products & Key Areas of Pharmaceutical R&D. |
|
|
Sep 6, 2006 |
426 |
| Cancer: Big C is no longer a death sentence; Cancer 2020 Birmingham scientists are developing cutting edge treatments and drugs which could significantly improve cancer patient survival rates. But Professor Alex Markham tells Health Reporter Emma Brady achievements like this will be pointless unless the Government commits to a new Cancer Plan. |
|
|
Sep 4, 2006 |
775 |
| TheWorldTonight: Cervical cancer vaccine boost. |
|
|
Sep 4, 2006 |
165 |
| Vaccines could cut cervical cancer. |
|
|
Sep 4, 2006 |
403 |
| Hana Biosciences Initiates Phase I Clinical Trial of a Targeted Chemotherapy Agent for Patients With Advanced Solid Tumors. |
|
|
Aug 3, 2006 |
1017 |
| Ovarian Cancer Drug Combination Identified at Rational Therapeutics Receives FDA Approval; Researchers Utilized Human Tumor Microspheroid Platform to Identify Novel Platin Plus Gemcitabine Combination for Ovarian Cancer in 1995. |
|
|
Jul 28, 2006 |
463 |
| Study at University of Texas Finds that Next Pharmaceutical's Nexrutine(R) Inhibits Prostate Cancer Cell Proliferation. |
|
|
Jul 27, 2006 |
509 |
| Widow joins anti-asbestos drug battle. |
|
|
Jul 1, 2006 |
432 |
| Wales News Bulletin Bodybuilders abuse cancer drugs. |
|
|
Jun 16, 2006 |
107 |
| Geron Announces Publication of First In Vivo Data Demonstrating Efficacy of GRN163l in Models of Primary and Metastatic Breast Cancer; Results Corroborate Recent Research with Novel Telomerase Inhibitor in Other Cancer Types. |
|
|
May 23, 2006 |
756 |
| HRT treatment 'increases risk of breast cancer'. |
|
|
May 9, 2006 |
370 |
| Cancer Research to help develop new drugs. |
|
|
May 8, 2006 |
375 |
| HEALTH MATTERS: Hope as shelved drugs revived. |
|
|
May 4, 2006 |
235 |
| AmpliMed Initiates Phase I Clinical Study of Benzimate in Patients with Advanced Refractory Cancer; New Formulation of Promising Cancer Drug Joins Amplimexon as Second Clinical-stage Compound in AmpliMed Portfolio. |
|
|
Apr 27, 2006 |
533 |
| Brittle bone drug hope for cancer. |
|
|
Apr 19, 2006 |
157 |
| Brittle bone drug hope for cancer. |
|
|
Apr 19, 2006 |
158 |
| Brittle bone drug hope for cancer. |
|
|
Apr 19, 2006 |
155 |
| New hope raised for treatment of cancer. |
|
|
Apr 19, 2006 |
398 |
| Abstracts on Callisto Drug Candidates from Degrasyn Class Presented at Scientific Conference on Cancer; Studies of Degrasyn Drug Candidates Highlight Mechanism-of-Action and Pharmacokinetic Properties of Selected Drug Candidates. |
|
|
Apr 19, 2006 |
914 |
| BioSante Pharmaceuticals Comments on New Data From Women's Health Initiative Study Showing No Increased Risk of Breast Cancer With Estrogen-Alone Therapy. |
|
|
Apr 17, 2006 |
1281 |
| Callisto Receives Approvals from Three Clinical Research Sites to Advance Clinical Trial of Atiprimod; Institutional Review Board Approvals Enable Study of Anti-Cancer Drug Candidate at Higher Dosage Levels. |
|
|
Apr 12, 2006 |
723 |
| Abstract on WP1066 Callisto Drug Candidate from Degrasyn Class Selected for Poster Presentation at Scientific Conference on Cancer; Degrasyn Drug Candidate Significantly Reduces Tumor in Animal Model of Head and Neck Squamous Cell Carcinoma. |
|
|
Apr 10, 2006 |
1013 |
| HEALTH MATTERS: Vaccine trials encouraging for treatment of cervical cancer. |
|
|
Apr 6, 2006 |
495 |
| VACCINE HOPE FOR CERVICAL CANCER; Pill could cut cases by 80 per cent. |
|
|
Apr 6, 2006 |
195 |
| ZIOPHARM Announces ZIO-101 Anti-Cancer Activity at AACR; Mechanism and Toxicity Profile of Arsenic Important in Treating Myeloma. |
|
|
Apr 5, 2006 |
558 |
| Geron Announces Initiation of Clinical Trial for Its Telomerase Inhibitor Drug GRN163L in Patients With Solid Tumor Malignancies. |
|
|
Apr 3, 2006 |
759 |
| Drug Development Platform Utilizes Ex-Vivo Analysis of Human Tumor Spheroids; Ovarian Cancer Study Demonstrates EVA(TM) Assay Applications for Targeted Therapies. |
|
|
Apr 3, 2006 |
464 |
| Cyclacel to Present Preclinical Data on Lead Clinical-Stage Drug, Seliciclib, at American Association for Cancer Research Annual Meeting. |
|
|
Mar 31, 2006 |
638 |
| Between 2010 and 2015 the Therapeutic Lung Cancer Drug Market is Expected to be Worth over $4 billion. |
|
|
Mar 24, 2006 |
191 |
| Callisto Pharmaceuticals Clinical Study of Anti-Leukemia Drug L-Annamycin Expanded to Third Clinical Site; Roswell Park Cancer Institute Commences Enrollment of Adult Leukemia Patients in Phase I/IIa Clinical Trial. |
|
|
Mar 21, 2006 |
1015 |
| $20 Million Gift from Arnold and Mabel Beckman Foundation Establishes New Model for Cancer Immunotherapy. |
|
|
Mar 21, 2006 |
1037 |
| Experienced Scientific Researcher Joins Advaxis to Advance Development of Cancer Vaccines. |
|
|
Feb 13, 2006 |
566 |
| Calando Pharmaceuticals Establishes Research Collaboration with National Cancer Institute to Develop RNAi Therapeutics; Cooperative Research and Development Agreement (CRADA) to Focus on RNAi Therapeutics -- to Target Neuroblastoma. |
|
|
Feb 3, 2006 |
696 |
| European Study Shows Promise of Intraoperative Radiation Therapy in Treatment of Early-Stage Breast Cancer. |
|
|
Jan 9, 2006 |
836 |
| Changing drug kills off cancer. |
|
|
Dec 29, 2005 |
239 |
| Cervical cancer vaccine for teens. |
|
|
Dec 19, 2005 |
235 |
| Breakthrough in cancer vaccine; Protection works best on adolescent girls, say researchers. |
|
|
Dec 19, 2005 |
451 |
| Callisto Cites New Research Data on Cancer Drug Atiprimod in Presentations at American Society of Hematology Meeting; Company Announces Plan for Next Phase of Trial Following Release of Additional Clinical and Pre-Clinical Data. |
|
|
Dec 14, 2005 |
1050 |
| Callisto Details Clinical Research Progress on Proprietary Anti-Cancer Drugs and Strategic Initiatives for 2006; Expected Start of Pediatric Trial of L-Annamycin to Treat Children with Leukemia Among Goals Noted in Investor Presentation. |
|
|
Dec 7, 2005 |
1036 |
| New Stanford Tool for Genetic Data Analysis May Improve Cancer Treatment. |
|
|
Dec 6, 2005 |
772 |
| Callisto Pharmaceuticals Announces Poster Presentation on Atiprimod at Major Scientific Meeting in December; Research on Atiprimod's Effect on Leukemia Cells to Be Presented at American Society of Hematology Annual Meeting. |
|
|
Dec 1, 2005 |
832 |
| pounds 700k will help us to beat cancer; Cash will boost new drug research. |
|
|
Nov 23, 2005 |
356 |
| Published Study Shows Benefits of Inovio's Selective Electrochemical Tumor Ablation Therapy as Head and Neck Cancer Treatment Option. |
|
|
Nov 18, 2005 |
934 |
| Distinguished Oncology Researcher, Dr. Robert Kerbel, Discusses the Therapeutic Potential of Pairing Vascular Disrupting Agents with Anti-Angiogenic Drugs in the Fight against Cancer at AACR Conference. |
|
|
Nov 10, 2005 |
1352 |
| Illumina to Conduct Large-Scale Genotyping for UK-Based Research Groups Studying Molecular Basis of Colorectal Cancer; Study Designed to Understand Genetic Susceptibility, Mechanisms of Disease Progression, and Cancer Therapy Management. |
|
|
Nov 9, 2005 |
1248 |
| Hormone replacement therapy does not improve breast cancer prognosis. |
|
|
Nov 1, 2005 |
188 |
| Private patients get life-saving medicine. |
|
|
Oct 31, 2005 |
146 |
| BREAST CANCER HOPE; Drug cuts chance of relapse by 46. |
|
|
Oct 20, 2005 |
348 |
| Clinical Trial at Arkansas Cancer Research Center Demonstrates Breast Cancer Treatment Using RITA Medical Systems Radiofrequency Ablation Products Reduces Re-Excision Rates by 86%. |
|
|
Oct 19, 2005 |
1485 |
| Retinoblastoma Researchers Find Success With Two-Drug Combination. |
|
|
Oct 17, 2005 |
480 |
| Pivotal Research Results Point to New Standard of Care That Reduces Risk of Esophageal Cancer; Photofrin(R) Photodynamic Therapy Spotlighted in October GIE Journal. |
|
|
Oct 11, 2005 |
938 |
| iCell Therapeutics Receives Support From the National Research Council's Industrial Research Assistance Program for Development of Cancer Treatment. |
|
|
Oct 10, 2005 |
430 |
| Callisto CEO Dr. Gary Jacob Discusses Research Progress on New Anti-Cancer Drug Candidates in Interview with WallSt.net; Company Chief to Provide Corporate Overview of KAL's Drug Development Programs. |
|
|
Oct 7, 2005 |
730 |
| Activating cancer drug discovery. |
Mead, M. Nathaniel |
|
Aug 15, 2004 |
895 |
| Radiation therapy or chemotherapy is often used as a treatment for certain types of cancer. |
|
|
Mar 22, 2004 |
207 |
| Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125. |
Nekulova, Mirka; Pecen, Ladislav; Kalabova, Renata; Simickova, Marta; Topolcan, Ondrej; Pikner, Rich |
|
Aug 1, 2002 |
2592 |
